商业实验室产前报告意义不明变异实践差异的影响:需更严格遵循已发表指南
该研究回顾性分析了124例因胎儿异常接受商业实验室全外显子组测序和靶向基因面板检测的病例,全外显子组测序和面板检测基于可能致病或致病变异的诊断率分别为21.5%和26%,42%的全外显子组测序和32%的面板分析报告了一个或多个意义不明变异,多学科深度审查使全外显子组测序和面板分析的诊断率分别提高5%和6%。
要点
- 全外显子组测序和面板检测基于可能致病或致病变异的诊断率分别为21.5%和26%。
- 42%的全外显子组测序和32%的面板分析报告了一个或多个意义不明变异。
- 多学科深度审查使全外显子组测序诊断率提高5%,面板分析提高6%。
核心结论
- 全外显子组测序和面板检测联合基于可能致病和致病变异的诊断率为23%。
- 尽管报告意义不明变异使全外显子组测序诊断率提高5%、面板分析提高6%,但商业实验室报告的大量意义不明变异具有显著的资源影响。
- 结果支持需要更严格遵循关于产前报告意义不明变异的建议,以及多学科方法整合产前遗传学和基因组学临床与实验室专业知识的重要性。
研究设计与样本
- 回顾性 chart review(病历审查),纳入124例因胎儿异常接受商业实验室测序的患者。
主要发现
- 全外显子组测序基于可能致病或致病变异的诊断率为21.5%,面板检测为26%。
- 42%的全外显子组测序分析和32%的面板分析报告了一个或多个意义不明变异。
- 对胎儿表型、疾病表型、变异数据以及部分患者的额外产前或产后检查进行多学科深度审查,使全外显子组测序分析的诊断率提高5%,面板分析提高6%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of implementing commercial whole exome sequencing (WES) and targeted gene panel testing in pregnancies with fetal anomalies. METHODS: A retrospective chart review of 124 patients with sequencing performed by commercial laboratories. RESULTS: The diagnostic yield of WES and panel testing was 21.5% and 26%, respectively, based on likely pathogenic (LP) or pathogenic (P) variants. Forty-two percent of exomes and 32% of panels analysed had one or more variants of uncertain significance (VUS) reported. A multidisciplinary in-depth review of the fetal phenotype, disease phenotype, variant data, and, in some patients, additional prenatal or postnatal investigations increased the diagnostic yield by 5% for exome analysis and 6% for panel analysis. CONCLUSIONS: The diagnostic yield of WES and panel testing combined was 23% based on LP and P variants. Although the reporting of VUS contributed to a 5% increase in diagnostic yield for WES and 6% for panels, the large number of VUS reported by commercial laboratories has significant resource implications. Our results support the need for greater adherence to the recommendations on the prenatal reporting of VUS and the importance of a multidisciplinary approach that brings together clinical and laboratory expertise in prenatal genetics and genomics.
引用
- Cornthwaite M, Turner K, Armstrong L, et al. Impact of variation in practice in the prenatal reporting of variants of uncertain significance by commercial laboratories: Need for greater adherence to published guidelines. Prenat Diagn. 2022. PMID: 36068917. doi:10.1002/pd.6232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。